For example, the use of ACE-inhibiting oligopeptides have been reported in the management of several diseases, including cardiovascular disease, increased blood pressure, type 2 diabetes, and obesity [50,51,52]. This evidence concerns the gene ACE and type 2 diabetes mellitus.